InvestorsHub Logo
Followers 5
Posts 528
Boards Moderated 0
Alias Born 07/16/2013

Re: fbg0316 post# 60541

Thursday, 03/22/2018 8:38:57 PM

Thursday, March 22, 2018 8:38:57 PM

Post# of 108192
But isn't NEO going to probably tackle cervical and head and neck cancer?

A Phase 1 Dose-Escalation Study of Advaxis (ADXS) NEO Expressing Personalized Tumor Antigens in Subjects With Metastatic Microsatellite Stable Colon Cancer, Metastatic Squamous Histology Head and Neck Cancer, and Metastatic Non-Small Cell Lung Cancer
Anticipated Study Start Date : March 2018

https://cervicalcancernews.com/2017/06/12/synthetic-genomics-launches-cgmp-suite-for-pharmaceutical-quality-manufacturing-of-synthetic-dna-for-advaxis-clinical-trials/

I am not a trained financial professional, and all posts are my bar stool amateur opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News